Home > Solutions > Consulting

Our team of analysts, epidemiologists, and evidence strategists represent decades of world-class training and experience. Partner with us to uncover solutions to your research challenges.

Meet the Team

Headshot photo of Kaylen Brzozowski
Kaylen Brzozowski
MPH, Senior Analyst

Before TriNetX
Yale School of Public Health ●  EIP (Emerging Infections Program)

Headshot photo of Elnara Fazio-Eynullayeva
Elnara Fazio-Eynullayeva
MA, Principal Research Scientist

Before TriNetX
Trinity Partners  ●  Truven Health Analytics ●  Harvard Pilgrim Health Care

Headshot photo of Harry Jin
Harry Jin
PhD, MPH, Principal Epidemiologist

Before TriNetX
Gilead  ●  ICON ●  San Francisco Department of Public Health

Headshot of Beni Turner
Beni Turner
Associate Manager, Chart Review Team

Before TriNetX
Xcenda ●  Navitus ● Outcomes Research Solutions, Inc.

Consulting Spotlight

Characteristics and Mortality Outcomes Among COVID-19 OutPatients in the United States

A collaboration with Merck & Co., Inc. and MSD (UK) Ltd.
Presented at ECCMID 2021

“The probability of all-cause 180-day mortality increased with greater levels of care received, 0.9% outpatient, 5.5% inpatient (without ICU), 26.7% ICU (without IMV/ECMO), and 39.4% ICU with IMV/ECMO  (p<0.001)… The probability of all-cause 180-day mortality was significantly in American Indian or Alaska Native (5.0%) and Black or African American (3.9%) races compared to White or Asian, Native Hawaiian or Pacific Islander races (both, 2.9%) (p<0.001).”